Advertisement

Antibodies to Klebsiella in Ankylosing Spondylitis Measured by Bacterial Agglutination and ELISA Against Lipopolysaccharides

  • Alan Ebringer
  • Alan Ebringer
Chapter

Abstract

The association between HLA-B27 and ankylosing spondylitis has been well established, and it has been suggested that Klebsiella bacteria may have a role to play in the pathogenesis of ankylosing spondylitis.

Keywords

Rheumatoid Arthritis Patient Ankylose Spondylitis Klebsiella Pneumoniae Rheumatic Fever Proteus Mirabilis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Ahmadi K, Wilson C, Tiwana H, Binder A, Ebringer A. Antibodies to Klebsiella pneumoniae lipopolysaccharide in patients with ankylosing spondylitis. Br J Rheumatol. 1998;37:1330–3.PubMedCrossRefGoogle Scholar
  2. Ciurana B, Thomas JM. Role of lipopolysaccharide and complement in susceptibility of Klebsiella pneumoniae to nonimmune serum. Infect Immun. 1987;55:2741–6.PubMedGoogle Scholar
  3. Ebringer A. Ankylosing spondylitis is caused by Klebsiella. Rheum Dis Clin North Am. 1992;18:105–21.PubMedGoogle Scholar
  4. Ebringer A, Ptaszynska T, Corbett M, Wilson C, Macafee Y, Avakian H, Baron P, James DCO. Antibodies to Proteus in rheumatoid arthritis. Lancet. 1985;ii:305–7.CrossRefGoogle Scholar
  5. Granfors K, Ogasawara M, Hill JL, Lahesmaa-Rantala R, Toivanen A, Yu DTY. Analysis of IgA antibodies to lipopolysaccharide in Yersinia-triggered reactive arthritis. J Infect Dis. 1989;159:1142–7.PubMedCrossRefGoogle Scholar
  6. Maki-Ikola O, Yli-Kerttula U, Saario R, Toivanen P. Granfors K. Antibodies to arthritis-associated microbes in inflammatory joint diseases. Rheumatol Int. 1991;10:231–4.PubMedCrossRefGoogle Scholar
  7. Maki-Ikola O, Lehtinen K, Nissila M, Granfors K. IgM, IgA and IgG class serum antibodies against Klebsiella pneumoniae and Escherichia coli lipopolysaccharides in patients with ankylosing spondylitis. Br J Rheumatol. 1994;33:1025–9.PubMedCrossRefGoogle Scholar
  8. Maki-Ikola O, Mertsola J, Granfors K. No endotoxin detected in the plasma in patients with ankylosing spondylitis. Ann Rheum Dis. 1997;56:279.PubMedCrossRefGoogle Scholar
  9. Robbins JB, McCracken GH, Gotschild EC, Orskov F, Orskov L, Hanson LA. Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis. N Engl J Med. 1974;290:1216–20.PubMedCrossRefGoogle Scholar
  10. Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA. Review of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958;3:175–6.PubMedCrossRefGoogle Scholar
  11. Tani Y, Sato H, Tanaka N, Mori K, Doida Y, Hukuda S. Serum IgA1 and IgA2 subclass antibodies against collagens in patients with ankylosing spondylitis. Scan J Rheum. 1997;26:380–2.PubMedCrossRefGoogle Scholar
  12. Wagener P, Bush J, Hammer M, Brunkhorst R. Endotoxin in the plasma of patients with inflammatory rheumatic diseases. Scand J Rheumatol. 1988;17:301–3.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  • Alan Ebringer
    • 1
  • Alan Ebringer
    • 2
    • 3
  1. 1.King’s College LondonLondonUK
  2. 2.UCH School of MedicineMiddlesex HospitalLondonUK
  3. 3.Division of Life SciencesKing’s College LondonLondonUK

Personalised recommendations